Related Experiment Video
Updated: Aug 1, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
Novel Biomarker Prediction for Lung Cancer Using Random Forest Classifiers.
Lavanya C1, Pooja S1, Abhay H Kashyap2
1Department of Biotechnology, RV College of Engineering, Bengaluru, Karnataka, India.
This study identifies key gene expression biomarkers for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) using machine learning. The Random Forest model accurately predicted biomarkers like BRAF for NSCLC and ATF6 for SCLC.
Area of Science:
- Genomics and Bioinformatics
- Cancer Research
- Computational Biology
Background:
- Lung cancer is a leading cause of cancer-related mortality, with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) as the primary types.
- Functional genomics and RNA-Seq have advanced the study of gene expression in tumors, but biomarker discovery remains challenging.
- Machine learning offers a promising approach to classify biomarkers based on gene expression patterns in different lung cancers.
Purpose of the Study:
- To compute transcript statistics and identify differential gene expression between lung cancer samples and the reference genome.
- To develop and evaluate machine learning models for classifying genes associated with NSCLC, SCLC, or both.
- To identify potential gene expression biomarkers for NSCLC and SCLC using transcriptome analysis.
Main Methods:
- Transcriptome data analysis, including normalized fold change and gene expression levels.
- Application of exploratory data analysis to understand feature distributions.
- Implementation and comparison of supervised (Logistic Regression, KNN, SVM, Random Forest) and ensemble (XGboost, AdaBoost) machine learning algorithms.
- Utilized Near Miss under-sampling to address dataset imbalance.
Main Results:
- The Random Forest classifier achieved 87% accuracy, identifying it as the best-performing model.
- BRAF, KRAS, NRAS, and EGFR were predicted as potential biomarkers for NSCLC.
- ATF6, ATF3, PGDFA, PGDFD, PGDFC, and PIP5K1C were predicted as potential biomarkers for SCLC.
- Common biomarkers for both NSCLC and SCLC included CDK4, CDK6, BAK1, CDKN1A, and DDB2.
- The fine-tuned model achieved 91.3% precision and 91% recall.
Conclusions:
- Machine learning, particularly the Random Forest classifier, is effective for identifying lung cancer biomarkers from gene expression data.
- Specific gene sets were identified as potential biomarkers for NSCLC and SCLC.
- Dataset limitations, including feature scarcity and imbalance, restrict further accuracy improvements but highlight the potential of this approach.
More Related Videos
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018